Oct 8th, 2023 (Shanghai) — We are glad to announce that Dr. Thomas A. Collet, the President & CEO of Bilayer Therapeutics, has been invited to present at ACCESS CHINA Partnering Forum on 11:15-11:30 am, October 17th, China time.
ACCESS CHINA Partnering Forum is the largest corporate access event between Asia and the western biopharma industry.
About the speaker
Thomas A. Collet, Ph.D.
President & CEO of Bilayer Therapeutics
Thomas A. Collet is a serial life sciences entrepreneur with deep drug development expertise. He serves as President, CEO and Director of Bilayer Therapeutics.
Dr. Collet has founded and led several life sciences companies including ProNAi Therapeutics (subsequently went public, now Sierra Oncology); Neural Intervention Technologies (subsequently acquired by W.L. Gore); and Rubicon Genomics (subsequently acquired by Takara Bio). He also served as Vice President of Business Development at Integrated Protein Technologies, a unit of Monsanto Company that Dr. Collet helped start.
Prior to entering the start-up space, Dr. Collet served as General Partner at Tullis-Dickerson & Company, a healthcare focused venture fund, and as a consultant at McKinsey & Company.
He earned a PhD in Biological Chemistry from the Massachusetts Institute of Technology and completed post-doctoral studies in Dr. Richard Lerner’s laboratory at The Scripps Research Institute.
About ACCESS CHINA Partnering Forum
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. We organize a series of online and in-person partnering events since 2019 with the mission to facilitate the collaboration between Western and Eastern biotechs.
This Autumn event, as part of our quarterly series, will feature 40+ leading pharmaceutical companies delivering virtual roadshows to an audience of 500+ participants online. During the event, audience can have access to innovative biopharmas and healthcare products from worldwide.
Event Name: ACCESS CHINA Partnering Forum-2023 Autumn
Date & Time: Oct. 16th-17th, 2023
Location: Zoom Webinar
Content: Keynote Speech, Company Showcase
Participants: Pharma/Biotech senior management and BDs.
View more information at https://biotochina.org/
“ACCESS CHINA 药通中国交易合作论坛2023”于2023年10月16日至17日线上举办。自2020年始，药通中国论坛系列活动已成功举办14届，成为了海内外生物医药、医疗器械企业寻找合作的领先跨境交易路演平台。这里聚集了海内外医药界顶尖BD和管理人员，为项目交流搭建了高效的沟通渠道，为资产交易创造了宝贵的机会。
大会名称：药通中国交易合作论坛2023
大会日期：2023.10.16-17（线上）
大会内容：主题演讲、海内外优质项目路演
参会观众：海内外医药企业（药企及Biotech）高管及BD、基金高管
查看更多信息： https://biotochina.org/
MORE INFORMATION
Contact US
Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
Wxiang@yafocapital.com
BioToChina.org 